Obesity has become one among the most serious health issues in US and Europe leading to other fatal diseases like heart stroke, diabetes etc. It even induces bizarre emotional reaction and if Vivus is able to give the patients a diet pill which reduces 10-13% body mass without drastic lifestyle change or threats then it will work wonders.
Qnexa the marvel is under final scrutiny and is awaiting approval from FDA. Lastly in the month of April it was almost approved and it had very positive response however its approval got delayed by two months due to a risk reduction plan requested by FDA. As the consumer sector for such a pill is too large almost 149 million people are suffering obesity in US alone therefore FDA wants to cross check everything once again before approving the medicine. Until today the clinical results of Qnexa is very positive and it can reduce almost 13-15% of body mass with minimum side effects.
Vivus has done a thorough research and development over the diet pill for years and both the key ingredients phentermine and topiramate are already approved medications for more than four decades. Many medical practitioners already prescribe the combination of these two drugs. Although people did question the side effects such as increased palpitation of heart beat, regain in weight etc but it has still received positive response from FDA. It has received recommendations from the association to buy Qnexa.

